Evidence map›Paper›PMID 27019804›Full record

ArticleWorld journal of methodology2016

Efficient management and maintenance of ultrasonic nebulizers to prevent microbial contamination.

Yoko Ida, Hiroaki Ohnishi, Kouji Araki, Ryoichi Saito, Shin Kawai, Takashi Watanabe

Open access · diamondAbstract read
In one paragraph

Article in World journal of methodology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yoko IdaYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Hiroaki OhnishiYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Kouji ArakiYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Ryoichi SaitoYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Shin KawaiYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Takashi WatanabeYoko Ida, Hiroaki Ohnishi, Kouji Araki, Takashi Watanabe, Clinical Laboratory, Kyorin University Hospital, Tokyo 181-8611, Japan.
Kyorin University Hospital · JPKyorin University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo seek the cause of Burkholderia cepacia complex (Bcc) infection outbreak and evaluate the efficacy of new methods for nebulizer maintenance.

methodsWe investigated the annual number of Bcc isolates recovered from clinical samples in our hospital between 1999 and 2013. Swab samples were randomly collected for bacterial culture before patient use from 10 each of the two machine types in August 2001; these included 20 samples from each of the following: Drain tubes, operating water chambers, oscillators, and nebulizing chambers. In addition, 10 samples each of nebulizer solutions before and after use were cultured. For environmental investigation, 10 samples were collected from sinks in the nurse stations of the wards where patients positive for Bcc were hospitalized. Numbers of Bcc isolates were compared before and after introduction of new methods for nebulizer maintenance in October 2001. In addition, randomly amplified polymorphic DNA (RAPD) assay was applied to find the genetic divergence of the Bcc isolates obtained from clinical samples and nebulizers.

resultsFrom January 1999 to December 2013, a total of 487 Bcc isolates were obtained from clinical specimens from 181 patients. Notably, 322 (66.1%) Bcc isolates were obtained from clinical specimens from 1999 to 2001, including 244 (115 patients) from sputum and 34 (11 patients) from blood. During this period, 14 isolates were obtained from nebulizer components. Among these, six were derived from nebulizer drain tubes, five from operating water chambers, and one from the oscillator before patient use, and two from nebulizer solutions after patient use. When Bcc was isolated from the nebulizer solution after patient use, Bcc was simultaneously detected in other parts of the nebulizer. Bcc was not isolated from any nebulizer solution before use. RAPD assays revealed similar DNA profiles in isolates obtained from patients and nebulizers. Investigation revealed damaged diaphragms in many nebulizers. The new maintenance methods for nebulizers, including restriction of the usage period, thorough disinfection, and routine check for diaphragm breakage, remarkably reduced Bcc isolation (165 isolates from patients in 12 years and 0 isolate from nebulizers in periodical sampling). In particular, Bcc has been isolated from blood from only one patient since the new methods were introduced.

conclusionAppropriate maintenance of ultrasonic nebulizers is crucial for preventing Bcc contamination of nebulizers and subsequent respiratory tract and blood infections.

Indexed as

Burkholderia cepaciaContaminationPreventionRandomly amplified polymorphic DNA assayUltrasonic nebulizer

Identifiers

PMID27019804
PMCPMC4804248
OpenAlexW2332643226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.